BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17710982)

  • 21. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.
    Lattouf JB; Grubb RL; Lee SJ; Bjurlin MA; Albert P; Singh AK; Ocak I; Choyke P; Coleman JA
    BJU Int; 2007 May; 99(5):1041-6. PubMed ID: 17437438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
    Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
    Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
    Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
    Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience.
    Prando A; Kurhanewicz J; Borges AP; Oliveira EM; Figueiredo E
    Radiology; 2005 Sep; 236(3):903-10. PubMed ID: 16118169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
    Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
    Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of methods of detection for prostate neoplasm].
    Zhong C; Chen M; Wan B
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):64-6. PubMed ID: 11783074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MRI for troubleshooting detection of prostate cancer].
    Beyersdorff D; Hamm B
    Rofo; 2005 Jun; 177(6):788-95. PubMed ID: 15902626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
    Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
    Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner.
    Singh AK; Krieger A; Lattouf JB; Guion P; Grubb RL; Albert PS; Metzger G; Ullman K; Smith S; Fichtinger G; Ocak I; Choyke P; Ménard C; Coleman J
    BJU Int; 2008 Jan; 101(2):181-5. PubMed ID: 17922874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
    Turkbey B; Xu S; Kruecker J; Locklin J; Pang Y; Shah V; Bernardo M; Baccala A; Rastinehad A; Benjamin C; Merino MJ; Wood BJ; Choyke PL; Pinto PA
    Cancer Imaging; 2011 Mar; 11(1):31-6. PubMed ID: 21450548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy.
    Schouten MG; Hoeks CM; Bomers JG; Hulsbergen-van de Kaa CA; Witjes JA; Thompson LC; Rovers MM; Barentsz JO; Fütterer JJ
    AJR Am J Roentgenol; 2015 Jul; 205(1):57-63. PubMed ID: 26102380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
    Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
    Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined usage of diffusion-weighted magnetic resonance imaging and transrectal ultrasound for transrectal prostate biopsy: a preliminary study].
    Wang JY; Shen YJ; Liu XH; Zhang HL; Ye DW; Yao XD; Zhang SL; Dai B; Zhu Y; Zhou LP
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):512-5. PubMed ID: 22490151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].
    Durmus T; Stephan C; Grigoryev M; Diederichs G; Saleh M; Slowinski T; Maxeiner A; Thomas A; Fischer T
    Rofo; 2013 May; 185(5):428-33. PubMed ID: 23420313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.